MediPocket USA - Cross Border Care的动态

My Learning’s in Achieving a Superior Patient Experience: The Vital Role of Medical Expertise Reflecting on our journey towards achieving a superior patient experience, we’ve come to realize the paramount importance of integrating medical expertise into healthcare companies. While it's encouraging to witness numerous ventures emerging to address oncology challenges, I urge you to recognize the pivotal role of medical professionals in guiding these endeavors. In our experience, the involvement of medical professionals in CARER - Personalised Cancer Care has been transformative. The guidance has been invaluable in shaping our offerings and optimizing patient outcomes. For anyone contemplating ventures in the healthcare sector, I strongly advocate for the inclusion of medical expertise. Beyond mere demonstration, harnessing the expertise of medical professionals ensures the delivery of impactful solutions. #IntegrativeOncology #HealthcareInnovation #MedicalExpertise #PatientCentricity

?? Exciting news from Viz.ai! ?? Six clinical studies unveiled at the 2024 International Stroke Conference highlight the impact of Viz? Neuro Suite on patient care. Real-world evidence highlights the positive impact of AI-powered care coordination on clinical workflow and patient outcomes. https://lnkd.in/e4Uw2ry7 #ISC24 #PatientsFirst

Such an important topic discussed today at #NORDSummit. The lack of standardized tools in rare disease research, and the feeling among patients that their data goes into a "black hole" shows that innovative approaches are needed desperately for rare disease communities. Direct input from patients to design better methods to measure their varied disease experiences, and making that data available to support better care decisions would be a great starting point to #MeasureWhatMattersMost in rare diseases!

Patients benefit enormously from research and innovation, with breakthroughs enabling prevention of ill-health, earlier diagnosis, more effective treatments, better outcomes and faster recovery.?Here at the National Centre for Stereotactic?Radiosurgery,?research?is paramount;?reviewing?clinical?and patient?data supports best practice,??provides routes to new treatments,?highlights diagnostic patterns and?this?information?helps?patients make informed decisions about their care. This work may also influence NHS funding decisions which can directly impact the availability of some treatments for specific pathologies. As a centre with almost 40 years experience treating many rare conditions with the latest Elekta technology, we regularly carry out clinical audit, service evaluation and research projects . The use of anonymised data from both the treatment and follow-up of patients is often used in these activities. Research has,?for example,?guided?international?treatment of large Arteriovenous Malformations?but also regularly drives service developments such as the use and benefits of trans-radial cerebral angiography within the service. Our department’s publications can be viewed in more detail at?https://lnkd.in/gHHqzCmy Patients are fully informed of the research ethos within the service and are able to opt out of their data being used at any time by simply informing one of our team who would then update their records to?reflect?this?decision. Our information booklets provide more information to patients on how research is used within the service and we hope that this reassures patients and their families as to how, why and when their data may be used. ? To enrich the?data, we?gather from within our service we may also?request?additional data from NHS England, or?other?governmental?bodies. Before?doing this, we apply?to the Health Research Authority's Confidentiality Advisory Group?for support?to use?limited?patient identifiable data without individual consent. This is called a Section 251 application and is mainly used for large studies of many hundreds or thousands of patients?. Again,?it is important that our patients know that this occurs and that they can opt out of any of their data being used by any NHS Trust at any time by completing a simple?declaration?at?https://lnkd.in/gFUPwtwN ? To find out more about research at the National Centre for Stereotactic Radiosurgery and the conditions we treat please visit our website at?www.gammaknife.org.uk #reseach #clinicalaudit #serviceevaluation #bestpractice #radiosurgery #LGK #gammaknife

Insights from our latest blog post on Keya Medical's AI-based CT-FFR analysis research and peer-reviewed publications. Our blog post provides a comprehensive overview of DEEPVESSEL FFR validation studies, showcasing its clinical performance, and impact on patient management. #CardiovascularHealth #MedicalInnovation #AIResearch #DEEPVESSELFFR #HealthTech #KeyaMedical #ADAPTStudy #ClinicalValidation #PeerReviewedPublications

The feasibility of delivering cardiac brief intervention to patients following ST-elevation myocardial infarction: Protocol for a pilot randomised controlled trial Feasibility of Cardiac Brief Intervention for ST-elevation Myocardial Infarction Patients Key Points: Patients often experience emotional distress and misconceptions after a heart attack. This study aims to assess the feasibility of providing a nurse-led, 20-minute emotional and educational support discussion, along with a memory-aid leaflet, to patients before discharge from the hospital. Participants will be recruited from two hospital centers in Northern Ireland, with half receiving the intervention and the other half receiving standard care information. Data will be collected at various time points to evaluate the intervention’s impact and feasibility. The study aims to address the educational and emotional challenges faced by heart attack patients, with the potential to improve cardiac rehabilitation participation and patient outcomes. Value of Clinical Trials and AI in Healthcare Practical Solutions: Clinical trials play a crucial role in developing safe and effective treatments, and it’s important to integrate their benefits into everyday medical practice. Our AI-driven platform, DocSym, consolidates clinical standards, protocols, and research, providing clinicians with a comprehensive knowledge base. In today’s healthcare environment, streamlining operations is essential. Our mobile apps support scheduling, treatment monitoring, and telemedicine, facilitating efficient patient care and digital service expansion. By leveraging AI, clinics can optimize workflows, enhance patient outcomes, and reduce paper-based routines. Visit aidevmd.com to learn more about how we can support your practice. https://lnkd.in/g2rcSMWH #ClinicalTrials #AIinHealthcare #MedicalAI #HealthTech #DigitalHealth #PatientCareAI #AIResearch #MedicalInnovation #BioTech #AIforGood #HealthcareData #AIinMedicine #PharmaAI #ClinicalData #HealthAI #AIHealthSolutions #PrecisionMedicine #AIandHealth #ClinicalAnalytics #AIDiagnostics

Patient data is one of our most powerful tools. This #NORDSummit panel, "Enhancing the Power of Patient Data," featured so many great quotes: Jill Kiernan from the Tatton Brown Rahman Syndrome (TBRS) Community Inc. said, "Our patient registry actually helped save a child’s life by identifying a critical heart issue that required surgery. It’s a clear example of how vital patient data can be." Dr. Kim Smith of FDA CDER said, "Patient-reported outcomes, like surveys on symptoms, are critical, especially for #RareDiseases where we lack standardized tools to measure the true patient experience." Dr. Rosa Sherafat-Kazemzadeh of #FDA CBER elaborated, "Natural history studies are crucial, especially in rare diseases, as they provide context for how a disease progresses without intervention, shaping our product development strategy." Dr. Yasmine Wasfi of Savara Inc. emphasized the importance of continued, transparent communication with patients: "Patients often feel like their data goes into a black hole after #ClinicalTrials, which is why we’ve started generating lay summaries and making data more accessible and transparent... By setting up patient advisory boards, we learned that even simple feedback—like sharing enrollment updates and intended publications—can build patient trust and engagement."

https://lnkd.in/dtvGSYcu Interesting case of #ai applied to real-world data to compare clinical outcomes between current and novel technologies in #medicaldevice. New frontiers are now opened.

2 Hour Live Talk with access to the recording, available to watch for 3 months after the event. Join us for an enlightening evening discussion tailored specifically for Healthcare Practitioners, as we delve into the intricate realm of hypomobility and the effective management of stiff patients. In this session, we will navigate through the complexities of hypomobility, exploring its underlying mechanisms, clinical manifestations, and implications for patient care. Current literature focuses on the hypermobile patient( see Tanya’s recorded presentation on HSD/hEDS: https://lnkd.in/duWkuHFf ) and the challenges this presents to clinicians. However, there is very little evidence-based literature available pertaining to the stiff patient. Genetically hypomobile, flexibility is challenging and doesn’t come naturally. This general stiffness is associated with compressive type overload, degeneration and overall poor mobility. Central to our discussion will be identifying this stiff patient group & optimally counselling them, as well as providing helpful treatment & rehabilitation strategies. These will include various therapeutic approaches designed to restore mobility and optimize function in stiff patients, such as manual therapy techniques, therapeutic exercises and patient education, addressing the unique needs of each patient. Tanya will also delve into the crucial role of interdisciplinary collaboration in managing hypomobility, highlighting the importance of a cohesive and integrated approach to patient care. Don't miss this opportunity to expand your knowledge, refine your skills, and unlock movement potential in your patients. To Register: https://lnkd.in/dHPeNTkx #movement #hypomobilty #stiffness #LiveTalk #CPDpoints #physiotherapy #healthcarepractitioners #biokineticist

“For a physician deciding in the moment which device might save a patient’s life, having that data to help guide their intuition could make a world of difference.” Learn how #REALPE, an #AI-powered study, is providing much-needed data to help physicians make the best treatment decisions for their #PE patients: https://bit.ly/42PgAI6 #WhyWeEKOS #EKOS Michael R. Jaff Peter Monteleone MD, FACC, FSCAI